Posoleucel’s third RMAT designation marks an unprecedented regulatory distinction among cell and gene therapies Global Phase 3 multi-virus prevention trial initiated in March 2022 and is enrolling patients WALTHAM, Mass., April 20, 2022–(BUSINESS WIRE)–AlloVir (Nasdaq: ALVR), a late clinical-stage allogeneic T cell immunotherapy company, today announced that the U.S. Food […]
prevention
Lessons from global survey data: What else can dental hygienists do to close the periodontal disease prevention gap?
Periodontal disease threatens both the physical and fiscal health of society. Periodontitis, especially in its advanced stages, is the main cause of tooth loss among adults, and its economic burden has been estimated to be $154.06 billion in the US and €158.64 billion in Europe.1 Additionally, Scientific American has recently […]